Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
CHELATEXX
- Development stage
- Preclinical
- Lead developer
- Chelatexx
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
CHELATEXX is an oral adsorbent therapy developed by Chelatexx for the treatment and prevention of hyperammonemia-related cognitive decline and Alzheimer's disease. The active ingredient is 360 mg of USP activated charcoal, formulated in an enteric-coated capsule designed to bypass the stomach and release in the distal ileum. This targeted delivery allows the charcoal to reach the colon approximately three hours after a meal, where it acts by physically adsorbing neurotoxic ammonia at its primary site of production. By binding ammonia in the gut, CHELATEXX prevents its absorption into the systemic circulation, thereby reducing the neurotoxic burden on the brain. The therapy is currently in preclinical development, with plans for Phase 2/3 clinical trials to evaluate its efficacy in slowing progressive cognitive decline.
- Brand names
- CHELATEXX
- Other names
- activated charcoal
Beyond the preview
Go deeper on CHELATEXX.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on CHELATEXX.